Back to top

INSM Maintained by Guggenheim -- Price Target Lowered to $205

INSM Maintained by Guggenheim -- Price Target Lowered to $205

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Insmed, Inc. (INSM)